Evinova

It was great to connect at #WorldADCLondon. As a science-led company, we’re passionate about delivering digital solutions that improve the patient experience with clinical trials and support optimal health outcomes from the next generation of transformative medicines. ? Are you considering remote patient monitoring for your ADC research? Please reach out – our team of experienced strategists and scientists can help. https://lnkd.in/egEKBznc #forhealthcarebyhealthcare

Antibody-drug conjugates (ADCs) hold tremendous promise in cancer research but carry nuanced toxicity risks that require a data?driven approach to dosing. ? At Evinova, we work with drug developers to address the specific challenges of ADC toxicity monitoring.?Our remote patient monitoring (RPM) modules are fit-for-purpose solutions to alert healthcare providers of the onset of symptoms of common ADC adverse events such as interstitial lung disease, nausea, vomiting, diarrhea or dehydration. This data enables HCPs to intervene proactively and make decisions about dosing in adherence with treatment guidelines. ? Discover how our technology supplements your ADC drug development strategy:?https://lnkd.in/evTH29ke? ? #WorldADCLondon

The Evinova team is attending #WorldADCLondon next week!? ? We’re excited to learn from global experts about the latest updates in antibody-drug conjugate (ADC) development and discuss how our effective, easy-to-use digital solutions can support optimal ADC dosing and adherence to treatment management guidelines to drive better patient outcomes.? ? Will you be there and want to connect? Fill out this form and our team will follow up:?https://lnkd.in/eYMBeEQf? ? World ADC Event Series: Gillian Livock MBA, James Thatcher, Will Wilson, Luis Garcia-Gancedo

Next week, don’t miss our Chief Commercial Officer, Gillian Livock MBA, at the BioIndustry Association (BIA) #WomeninBiotech event in Cambridge.? ? Gill will join a panel of experts to discuss how greater diversity in data and clinical trials can lead to better healthcare outcomes. ? Register here -?https://lnkd.in/e5ZBCfZQ

At Evinova, we’re focused on accelerating better health outcomes through digital solutions for common clinical challenges such as toxicity monitoring.? ? Remote patient monitoring (RPM) relies on digital tools to track patients' health data outside of traditional clinical settings. By collecting data in real-time and sending alerts, RPM facilitates: - Evidence-based communication between patients and healthcare providers? - Faster triage of patients in need of further evaluation to mitigate risk - Proactive clinical decision making based on data Learn more about the power of RPM and contact us if you are interested in hearing about our fit-for-purpose solutions available to propel your research forward?-??https://lnkd.in/eaciJGw3

We’re excited to welcome Jiajie Zhang as Evinova’s new Chief Data Science & AI Officer! ? Data science, AI and machine learning are at the heart of Evinova’s innovative platforms and products—powering how we measure the patient journey, enhance study execution, and drive operational efficiencies. ? Jiajie brings deep expertise in AI-driven diagnostics, drug discovery, and digital health solutions, having previously held positions of increasing responsibility at a number of pharmaceutical and biotech companies. His leadership will be instrumental in advancing our core human-centered AI approach.? ? Welcome, Jiajie! Learn more about our leadership team here:? https://lnkd.in/eSW25b_j Cristina Ortega Duran, Sean Connolly, Ami Mehr, Jill Bell, Jiajie Zhang, Gillian Livock MBA, Matthew Bonam, Thomas Sutton, Andrea Rudy Rubio, FCCA, Dawn Plowman, Adam McArthur

With remote patient monitoring (RPM) for toxicities in a clinical trial, real-time data collection and alerts can be used by healthcare providers to provide more proactive care, with the goal to mitigate risk and improve outcomes. ? Learn more about the power of toxicity monitoring with RPM and Evinova’s solutions here -??https://lnkd.in/eaciJGw3

Toxicity management with remote patient monitoring (RPM) has the potential to transform clinical trials. ? Evinova’s RPM solution collects data about a patient’s health and sends alerts about potential toxicities in real-time. With this important information, HCPs can review, intervene early and make proactive decisions about a patient’s medical care based on guidelines. ? ? Backed by science and designed around clinical need, Evinova delivers fit-for-purpose RPM solutions that can help HCPs deliver better outcomes for patients. Learn more here -?https://lnkd.in/eaciJGw3

That’s a wrap on #SCOPESummit 2025! During the conference, Evinova experts took the stage to talk about hot topics in clinical research including: - Working together to drive innovative clinical trial recruitment strategies - Harnessing patient-centric tools and data collection to create tangible benefits for site teams?and engage patients - Increasing adoption of digital endpoints while maintaining a focus on reducing patient burden ? In between sessions, our team enjoyed making connections and discussing the many ways science and technology can propel clinical development into the future. ? What was your favorite part of #SCOPESummit? Let us know below!

Excited for SCOPE Summit 2025? ? Join Kelly McKee, Head of Innovative Patient Recruitment at Evinova for the panel "Rethinking Recruitment: The Value of Site-Centric Enablement with Sponsor, Site & Vendor Alignment" on February 4th at 12:35 pm. ? The panel will dive into how adopting a collaborative, aligned strategy can transform patient recruitment. ? Be sure to mark your calendars and check out the full agenda here:?https://lnkd.in/d9ZPiM7